Company Filing History:
Years Active: 1992-2012
Title: Kirk E Fry - Innovator in Autoimmune Disease Diagnosis
Introduction
Kirk E Fry is a distinguished inventor based in Palo Alto, CA, who has made significant contributions to the field of diagnostics, particularly in autoimmune diseases. With a remarkable portfolio of 39 patents to his name, Fry's work focuses on advancing methods for diagnosing complex conditions like systemic lupus erythematosus (SLE).
Latest Patents
Fry's recent patents exemplify his dedication to improving patient care. One notable invention describes methods for diagnosing and monitoring the status of systemic lupus erythematosus. This innovative method involves detecting the expression of genes in a diagnostic set, allowing for an accurate assessment of SLE classification and status. Another significant patent discusses methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases. This invention emphasizes the use of gene expression levels to provide insights into these conditions, including SLE, thereby enhancing disease management.
Career Highlights
Throughout his career, Kirk E Fry has collaborated with prominent companies such as Genelabs Technologies, Inc. and XDX, Inc. These associations demonstrate his active engagement in research and development efforts aimed at tackling complex medical challenges. His inventions have paved the way for better diagnostic tools, ultimately improving outcomes for patients suffering from autoimmune diseases.
Collaborations
Fry has worked alongside notable individuals in the industry, including Jay Wohlgemuth and Robert Woodward. These collaborations have contributed to the advancement of diagnostic methodologies and the overall understanding of autoimmune conditions, further establishing Fry as a leading figure in his field.
Conclusion
Kirk E Fry's innovative contributions to the diagnosis and monitoring of autoimmune diseases underscore his role as a key inventor in the medical field. With 39 patents to his name, his work continues to influence the landscape of diagnostic technology, providing hope and improved care for patients battling conditions like systemic lupus erythematosus.